Keywords: bipolar disorder, drug treatment, mood disorders, mania, schizophrenia, depression mayorLineamientos consensus of experts for the pharmacological treatment of bipolar disorder: a new therapeutic tool Dr. David A. Kahn, Dr. Gary S. Sachs, Dr. David J. Printz, Prof. Daniel Carpenter, Dr. John P. Docherty, and Prof. Ruth Ross Introduction [...]
Therapeutic and diagnostic ADHD Guide - Part I Dr. Peter S. Jensen and Ms. Maura Crowe Background disorder attention deficit hyperactivity disorder (ADHD) is the most common behavioral / emotional disorder among school-age children and adolescents. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (Diagnostic and Statistical [...]
Delirium Trihexyphenidyl Hydrochloride Dr. Andres and Dr. Jaime Solis Heerlein Summary For a patient of 17 years old, single, student, who is taken by her parents to consult the emergency service by behavioral problems, disorientation, paranoid and suicidal ideation, secondary use of trihexyphenidyl hydrochloride associated with consumption is presented [...]
Light therapy for seasonal depressive disorder Dr. Andrés Heerlein Introduction Since the work of Rosenthal and colleagues1 pioneers of seasonal affective disorder (SAD) and phototherapy, many authors have stressed the need to include this kind of therapeutic tool in the treatment guidelines disorders ánimo.1-3 Light therapy was first introduced [...]
2007 Edition, N. 3 MEDWORKS Vol. 40 - No. 2 - 2007 ------------------------------------------------------------------------ THE TRIALS AND TRIBULATIONS OF ARIPIPRAZOLE The objective of the study was to assess the efficacy and safety of aripiprazole in outpatients with post traumatic stress disorder (PTSD) on a 12-week, open-label trial. Twenty-two subjects with DSM-IV [...]
Publisher’s Statement New York: 9/11/01 A Personal Reckoning By James La Rossa Jr. There are two roadway approaches to New York City from which the awesome grandeur and sheer power of this metropolis come clearly into focus. Just prior to entering either the Midtown or the Holland Tunnels, you come [...]
Pharmaceutical Complex Zyban Rising: Smokers Thwart Insurance Carriers But Get What They Pay for By James La Rossa Jr. While the latest smoking cessation therapy utilizing the compound Zyban is making the rounds of newspapers and television news programs, its identical twin, bupropion, or Wellbutrin SR, is getting the lion’s [...]
Point & Commentary Physicians Back in the Driver’s Seat By James M. La Rossa Jr. At the beginning of 1997, the seasoned CBS newsman, Mike Wallace, and his wife Mary, sat for a portrait cover of the first Mental Fitness Consumer edition.1 Wallace’s honest disclosure about his suicidal depression was [...]
Guest Editorial A u t i s m : A Personal Insight B y T e m ple G r a n d i n , P h D W hen I wa s 3, I had a ll the sy mptoms of autism— no speech, tantrums, self-stimulatory behavior, and [...]
EDITOR’S NOTE The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry By Michael E. Thase, MD It is both an honor and a ch a llenge to assume the helm as editor of P sy ch o p h a rm ac o l [...]